Crowley Michael
EVP, GBL Commercial Operations at BIO
- Sold, on record
- $7M
- Dollars the filings state
- Form 4 sales
- 24
- Latest Mar 14, 2025
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOBIO-RAD LABORATORIES, INC.EVP, GBL Commercial Operations
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIONo planNov 28, 2023 2023
Sold 642 shares at $305.10 ($196k)
Crowley Michael, EVP, GBL Commercial Operations
No 10b5-1 planSold 8.5% of holdings ($2.3M position)6,942 shares leftFollows a Form 144Filing
- 2 Form 144 notice BIONoticeNov 28, 2023 same day
Filed to sell 642 shares ($196k)
Crowley Michael, Officer
No 10b5-1 planFiling
- 3 Form 144 notice BIONoticeFeb 27, 2024 +91 days
Filed to sell 3,000 shares ($1M)
Crowley Michael, Officer
No 10b5-1 planFiling
- 4 Form 4 sale BIOUnusualFeb 27, 2024 same day
Sold 3,000 shares at $336.00 ($1M)
Crowley Michael, EVP, GBL Commercial Operations
No 10b5-1 planSold 30.2% of holdings ($3.3M position)6,942 shares leftFollows a Form 144Filing
- 5 Form 144 notice BIONoticeJun 13, 2024 +107 days
Filed to sell 369 shares ($104k)
Crowley Michael, Officer
No 10b5-1 plan0.6x usual sizeFiling
- 6 Form 4 sale BIONo planJun 13, 2024 same day
Sold 369 shares at $281.91 ($104k)
Crowley Michael, EVP, GBL Commercial Operations
No 10b5-1 planSold 5.3% of holdings ($2M position)6,573 shares left0.6x usual sizeFollows a Form 144Filing
- 7 Form 144 notice BIONoticeMar 13, 2025 +273 days
Filed to sell 3,000 shares ($780k)
Crowley Michael, Officer
No 10b5-1 plan5.3x usual sizeFiling
- 8 Form 4 sale BIOUnusualMar 14, 2025 +1 day
Sold 3,000 shares at $247.06 ($741k)
Crowley Michael, EVP, GBL Commercial Operations
No 10b5-1 planSold 26.9% of holdings ($2.8M position)8,171 shares left5.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (29)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Mar 18, 2025 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 3,000 | $741k | 26.9% | Unusual | SEC |
| Mar 13, 2025 | Mar 13, 2025 | BIO | Officer | Form 144 notice | 3,000 | $780k | Notice | SEC | |
| Jun 13, 2024 | Jun 14, 2024 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 369 | $104k | 5.3% | No plan | SEC |
| Jun 13, 2024 | Jun 13, 2024 | BIO | Officer | Form 144 notice | 369 | $104k | Notice | SEC | |
| Feb 27, 2024 | Feb 28, 2024 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 3,000 | $1M | 30.2% | Unusual | SEC |
| Feb 27, 2024 | Feb 27, 2024 | BIO | Officer | Form 144 notice | 3,000 | $1M | Notice | SEC | |
| Nov 28, 2023 | Nov 28, 2023 | BIO | Officer | Form 144 notice | 642 | $196k | Notice | SEC | |
| Nov 28, 2023 | Nov 28, 2023 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 642 | $196k | 8.5% | No plan | SEC |
| Jun 15, 2023 | Jun 16, 2023 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 500 | $190k | 7.6% | No plan | SEC |
| Jun 15, 2023 | Jun 15, 2023 | BIO | Officer | Form 144 notice | 500 | $190k | Notice | SEC | |
| Aug 9, 2021 | Aug 10, 2021 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 3,000 | $2.3M | 45.0% | Unusual | SEC |
| Dec 15, 2020 | Dec 17, 2020 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 374 | $217k | 9.3% | Plan not stated | SEC |
| Jun 1, 2020 | Jun 2, 2020 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 1,500 | $728k | 39.4% | Unusual | SEC |
| Sep 4, 2019 | Sep 5, 2019 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 1,089 | $363k | 35.1% | Unusual | SEC |
| Aug 14, 2019 | Aug 14, 2019 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 325 | $104k | 9.5% | Plan not stated | SEC |
| Dec 14, 2018 | Dec 14, 2018 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 392 | $97k | 10.3% | Plan not stated | SEC |
| Jun 13, 2018 | Jun 14, 2018 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 350 | $106k | 14.0% | Plan not stated | SEC |
| Dec 4, 2017 | Dec 4, 2017 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 1,000 | $258k | 28.6% | Unusual | SEC |
| Aug 11, 2017 | Aug 11, 2017 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 700 | $151k | 25.4% | Unusual | SEC |
| Mar 7, 2017 | Mar 8, 2017 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 300 | $59k | 9.8% | Plan not stated | SEC |
| Nov 7, 2016 | Nov 8, 2016 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 88 | $15k | 2.8% | Plan not stated | SEC |
| Sep 13, 2016 | Sep 14, 2016 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 127 | $20k | 4.2% | Plan not stated | SEC |
| Sep 12, 2016 | Sep 13, 2016 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 523 | $81k | 16.2% | Plan not stated | SEC |
| Aug 18, 2016 | Aug 18, 2016 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 669 | $102k | 26.4% | Unusual | SEC |
| Nov 13, 2015 | Nov 16, 2015 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 549 | $75k | 17.8% | Unusual | SEC |
| Sep 14, 2015 | Sep 15, 2015 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 270 | $38k | 8.4% | Plan not stated | SEC |
| Sep 11, 2015 | Sep 14, 2015 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 152 | $21k | 5.7% | Plan not stated | SEC |
| Sep 9, 2015 | Sep 10, 2015 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 97 | $13k | 4.1% | Plan not stated | SEC |
| Mar 10, 2015 | Mar 12, 2015 | BIO | EVP, GBL Commercial Operations | Form 4 sale | 200 | $27k | 8.7% | Plan not stated | SEC |